Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EBS Emergent Biosolutions

盘后交易 07-14 17:37:04 EDT

7.30

-0.06

-0.82%

盘后7.60

+0.30+4.11%

17:18 EDT

最高7.65	最低7.12	成交量129.87万
今开7.33	昨收7.36	日振幅7.20%
总市值3.96亿	流通市值3.85亿	总股本5,428万
成交额955.57万	换手率2.46%	流通股本5,280万
市净率0.72	ROE-21.63%	每股收益-2.46
52周最高15.10	52周最低4.02	市盈率-2.97
股息0.00	股息收益率0.00	ROA-1.61%

北京优虎网络科技有限公司

{"stockData":{"symbol":"EBS","market":"US","secType":"STK","nameCN":"Emergent Biosolutions","latestPrice":7.3,"timestamp":1752523200000,"preClose":7.36,"halted":0,"volume":1298719,"hourTrading":{"tag":"盘后","latestPrice":7.6,"preClose":7.3,"latestTime":"17:18 EDT","volume":11950,"amount":87240.3058,"timestamp":1752527902748},"delay":0,"floatShares":52797540,"shares":54277827,"eps":-2.457516,"marketStatus":"盘后交易","change":-0.06,"latestTime":"07-14 17:37:02 EDT","open":7.33,"high":7.65,"low":7.12,"amount":9555672.5797044,"amplitude":0.072011,"askPrice":7.59,"askSize":2500,"bidPrice":6.41,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.457516,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752537600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1254456000000,"exchange":"NYSE","adjPreClose":7.36,"preHourTrading":{"tag":"盘前","latestPrice":7.36,"preClose":7.34,"latestTime":"09:27 EDT","volume":1278,"amount":9274.619808,"timestamp":1752499671581},"postHourTrading":{"tag":"盘后","latestPrice":7.6,"preClose":7.3,"latestTime":"17:18 EDT","volume":11950,"amount":87240.3058,"timestamp":1752527902748},"volumeRatio":1.138614,"impliedVol":0.0831,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/EBS","defaultTab":"news","newsList":[{"id":"2550065555","title":"Emergent Biosolutions Inc.盘中异动 早盘股价大涨5.17%报7.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550065555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550065555?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:35","pubTimestamp":1752068100,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时35分，Emergent Biosolutions Inc.股票出现异动，股价快速拉升5.17%。截至发稿，该股报7.22美元/股，成交量5.0217万股，换手率0.09%，振幅3.35%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为0.96%。其相关个股中，Evoke Pharma, Inc.、Medicus Pharma Ltd.、Biofrontera Inc.涨幅较大，Evoke Pharma, Inc.、Incannex Healthcare Inc.、Medicus Pharma Ltd.较为活跃，换手率分别为2649.19%、9.45%、3.98%，振幅较大的相关个股有Evoke Pharma, Inc.、Medicus Pharma Ltd.、Tilray Brands, Inc.，振幅分别为60.89%、8.36%、6.06%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213500953c3509&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213500953c3509&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4139","EBS"],"gpt_icon":0},{"id":"2549155476","title":"Emergent Biosolutions Inc.盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549155476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549155476?lang=zh_cn&edition=full","pubTime":"2025-07-08 02:18","pubTimestamp":1751912329,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日02时18分，Emergent Biosolutions Inc.股票出现波动，股价大幅下挫5.01%。截至发稿，该股报6.64美元/股，成交量40.0435万股，换手率0.74%，振幅4.15%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为1.14%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708021850a69b6c5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708021850a69b6c5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EBS","BK4583"],"gpt_icon":0},{"id":"2548688687","title":"Emergent Biosolutions Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548688687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548688687?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:11","pubTimestamp":1751386301,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时11分，Emergent Biosolutions Inc.股票出现异动，股价快速拉升5.03%。截至发稿，该股报6.70美元/股，成交量30.677万股，换手率0.57%，振幅7.60%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为1.12%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001142a728c9a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001142a728c9a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4139","EBS"],"gpt_icon":0},{"id":"2541830640","title":"证监会同意瑞立科密深交所主板IPO注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2541830640","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541830640?lang=zh_cn&edition=full","pubTime":"2025-06-06 17:20","pubTimestamp":1749201635,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，6月6日，中国证监会发布《关于同意广州瑞立科密汽车电子股份有限公司首次公开发行股票注册的批复》。据悉，瑞立科密拟在深交所主板上市，中信证券为其保荐机构，拟募资15.2162亿元。招股书显示，瑞立科密是专业从事机动车主动安全系统相关核心部件研发、生产和销售的国家高新技术企业，主营业务为机动车主动安全系统和铝合金精密压铸件的研发、生产和销售以及技术服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1302286.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"2536068423","title":"瑞立科密冲刺上市，招股书因何引用陈旧行业数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2536068423","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536068423?lang=zh_cn&edition=full","pubTime":"2025-05-19 20:49","pubTimestamp":1747658940,"startTime":"0","endTime":"0","summary":"业内人士认为，保荐机构有责任更新招股书行业数据。对瑞立科密而言，2025年5月6日披露的这一份招股书注册稿，引用大量行业数据来自2023年，甚至2020年版本的汽车电子行业研究报告，在汽车行业出现翻天覆地变化的这几年，如此漠视更新数据，让业内人士感到困惑。即使便于查找的汽车行业销量数据，公司最新版招股书都没有更新引用最近年度的数据。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-05-19/doc-inexcfvr0752306.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-05-19/doc-inexcfvr0752306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"2535207013","title":"Emergent Biosolutions Inc.盘中异动 下午盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535207013","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535207013?lang=zh_cn&edition=full","pubTime":"2025-05-13 01:23","pubTimestamp":1747070630,"startTime":"0","endTime":"0","summary":"北京时间2025年05月13日01时23分，Emergent Biosolutions Inc.股票出现波动，股价快速上涨5.04%。截至发稿，该股报5.94美元/股，成交量70.5893万股，换手率1.30%，振幅4.84%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为2.56%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513012350a6dc8290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513012350a6dc8290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4139","BK4583"],"gpt_icon":0},{"id":"2533350721","title":"瑞立科密深交所IPO提交注册 为国内商用车主动安全系统龙头企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2533350721","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533350721?lang=zh_cn&edition=full","pubTime":"2025-05-06 18:01","pubTimestamp":1746525676,"startTime":"0","endTime":"0","summary":"最近三年，瑞立科密商用车销量分别为 330.05 万辆、403.10 万辆和 387.30 万辆，不考虑出口因素，公司商用车 ABS、ESC、EBS 产品合计境内销售分别约 79.21 万套、95.60 万套和 108.13 万套，假设一辆商用车配置一套行车制动系统，公司 ABS、ESC、 EBS 产品在商用车领域的市场份额分别为 24.00%、23.72%和 27.92%，稳居行业领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"2529870683","title":"瑞立科密深交所IPO过会：年营收近20亿应收账款账面价值6亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2529870683","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529870683?lang=zh_cn&edition=full","pubTime":"2025-04-21 19:33","pubTimestamp":1745235229,"startTime":"0","endTime":"0","summary":"广州瑞立科密汽车电子股份有限公司（简称：“瑞立科密”）日前IPO过会，准备计划募资15.2亿元在深交所主板上市。招股书显示，瑞立科密2022年、2023年、2024年营收分别为13.26亿元、17.6亿元、19.77亿元；","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250421/6388086082138345074022854.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250421/6388086082138345074022854.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n29755/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2529819055","title":"瑞立科密深交所IPO通过上市委会议 ABS产销连续10年排名行业第一位","url":"https://stock-news.laohu8.com/highlight/detail?id=2529819055","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529819055?lang=zh_cn&edition=full","pubTime":"2025-04-21 09:34","pubTimestamp":1745199266,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月18日，广州瑞立科密汽车电子股份有限公司通过深交所主板上市委会议审议。根据中国汽车工业协会统计，2014年至2023年，公司气压电控制动产品包含的制动防抱死装置产量和销量连续10年排名行业第一位。财务方面，于2024年度、2023年度、2022年度，瑞立科密实现营业收入分别约为19.77亿元、17.60亿元、13.26亿元；同期，净利润分别约为2.75亿元、2.39亿元、1.05亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","EBS","BK4583"],"gpt_icon":0},{"id":"2528731266","title":"隐形冠军20年磨一剑：瑞立科密IPO闯关背后的中国汽车主动安全系统突围战","url":"https://stock-news.laohu8.com/highlight/detail?id=2528731266","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528731266?lang=zh_cn&edition=full","pubTime":"2025-04-17 11:33","pubTimestamp":1744860780,"startTime":"0","endTime":"0","summary":"至2024年，我国商用车销量387.3万辆，公司ABS、ESC、EBS产品销量达到108.13万套，市场占有率接近28%，意味着每四辆商用车中就有一辆搭载瑞立科密的安全系统。亮眼的业绩背后，是瑞立科密在商用车主动安全系统和铝合金精密压铸件两大业务上的协同发力。面对这一历史性机遇，深耕汽车主动安全系统领域的瑞立科密展现出敏锐的战略眼光。技术布局方面，瑞立科密已率先卡位行业高点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-04-17/doc-inetmuvw6055539.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-17/doc-inetmuvw6055539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2527194427","title":"Emergent Biosolutions Inc.盘中异动 快速拉升5.01%报4.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527194427","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527194427?lang=zh_cn&edition=full","pubTime":"2025-04-14 23:10","pubTimestamp":1744643404,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日23时10分，Emergent Biosolutions Inc.股票出现异动，股价快速上涨5.01%。截至发稿，该股报4.61美元/股，成交量25.0661万股，换手率0.46%，振幅6.15%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为1.91%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041423100497379491&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041423100497379491&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2518822412","title":"Emergent Biosolutions Inc.盘中异动 早盘快速下跌5.20%报5.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518822412","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518822412?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613729,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Emergent Biosolutions Inc.股票出现波动，股价大幅跳水5.20%。截至发稿，该股报5.47美元/股，成交量5.3544万股，换手率0.10%，振幅1.56%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.64%。其相关个股中，Sonoma Pharmaceuticals, Inc.、Alpha Teknova, Inc.、Flora Growth Corp.涨幅较大，Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为52.14%、8.77%、2.85%，振幅较大的相关个股有Shuttle Pharmaceuticals Holdings, Inc.、惠普森医药、Alpha Teknova, Inc.，振幅分别为13.84%、12.67%、12.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213529a26a2645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213529a26a2645&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2516677553","title":"Emergent Biosolutions Inc.股价重挫15.96% 市值跌4963.83万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677553","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677553?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098779,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Emergent Biosolutions Inc.股票出现异动，股价快速下跌15.96%。截至发稿，该股报5.74美元/股，成交量35.3898万股，换手率0.65%，振幅4.39%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.02%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223259abe7f004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223259abe7f004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EBS","BK4583"],"gpt_icon":0},{"id":"2516966912","title":"Emergent BioSolutions(EBS.US)：2024年Q4财报实现营收1.947亿美元，前值为2.766亿美元，预期值为2.547亿美元；每股收益为0.05美元，前值为-0.77美元，预期值为-0.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516966912","media":"金融界","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516966912?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:32","pubTimestamp":1741037576,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions(EBS.US)：2024年Q4财报实现营收1.947亿美元，前值为2.766亿美元，预期值为2.547亿美元；每股收益为0.05美元，前值为-0.77美元，预期值为-0.50美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04053248499197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EBS"],"gpt_icon":0},{"id":"1101283831","title":"Emergent BioSolutions第四季度调整后每股收益$0.05，超出预期$(0.49)，销售额$194.70M不及预期$254.67M","url":"https://stock-news.laohu8.com/highlight/detail?id=1101283831","media":"财报速递","labels":["merge","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101283831?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:31","pubTimestamp":1741037470,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions报告的季度每股收益为$0.05，比分析师预期的$高出110.2%。公司报告的季度销售额为$194.70M，不及分析师预期的$254.67M，低23.55%。这比去年同期的销售额$276.60M减少了29.61%。以上内容来自Benzinga Earnings专栏，原文如下：Emergent BioSolutions  reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $ by 110.2 percent. This is a 106.49 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $194.70 million which missed the analyst consensus estimate of $254.67 mi","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Emergent BioSolutions第四季度调整后每股收益$0.05，超出预期$(0.49)，销售额$194.70M不及预期$254.67M","news_tag":"merge,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS"],"gpt_icon":0},{"id":"2516765030","title":"Emergent Biosolutions Inc.盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516765030","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516765030?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:28","pubTimestamp":1741030121,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时28分，Emergent Biosolutions Inc.股票出现异动，股价快速下跌5.01%。截至发稿，该股报7.11美元/股，成交量86.0413万股，换手率1.59%，振幅6.63%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为1.03%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304032841a25d920f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304032841a25d920f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EBS","BK4583"],"gpt_icon":0},{"id":"2516237176","title":"Emergent Biosolutions Inc.盘中异动 临近午盘股价大涨5.10%报7.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516237176","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516237176?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:48","pubTimestamp":1740761281,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时48分，Emergent Biosolutions Inc.股票出现异动，股价快速拉升5.10%。截至发稿，该股报7.42美元/股，成交量25.5917万股，换手率0.47%，振幅6.37%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.10%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010048019634390c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010048019634390c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EBS","BK4583"],"gpt_icon":0},{"id":"2513781327","title":"Emergent Biosolutions Inc.盘中异动 急速跳水5.19%报7.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513781327","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513781327?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:28","pubTimestamp":1740410881,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时28分，Emergent Biosolutions Inc.股票出现异动，股价大幅下挫5.19%。截至发稿，该股报7.31美元/股，成交量32.9475万股，换手率0.61%，振幅4.86%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为0.75%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242328039891035c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242328039891035c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2512489924","title":"Emergent Biosolutions Inc.盘中异动 大幅下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512489924","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512489924?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:31","pubTimestamp":1739979095,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时31分，Emergent Biosolutions Inc.股票出现异动，股价急速下跌5.16%。截至发稿，该股报7.91美元/股，成交量48.0852万股，换手率0.89%，振幅4.44%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为0.87%。其相关个股中，坎伯兰药业、Gelteq Limited、和黄医药涨幅较大，Petros Pharmaceuticals, Inc.、Painreform Ltd.、大自然药业较为活跃，换手率分别为36.19%、29.93%、8.63%，振幅较大的相关个股有坎伯兰药业、Painreform Ltd.、Medicus Pharma Ltd.，振幅分别为12.24%、10.24%、9.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219233135a24c07b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219233135a24c07b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"2512193283","title":"Emergent Biosolutions Inc.盘中异动 下午盘大幅跳水5.14%报9.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512193283","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512193283?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:14","pubTimestamp":1739902489,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时14分，Emergent Biosolutions Inc.股票出现异动，股价快速下挫5.14%。截至发稿，该股报9.22美元/股，成交量49.1939万股，换手率0.91%，振幅6.77%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为1.91%。其相关个股中，Painreform Ltd.、Flora Growth Corp.、Indivior Plc涨幅较大，Painreform Ltd.、Petros Pharmaceuticals, Inc.、Cbdmd, Inc.较为活跃，换手率分别为4824.40%、234.00%、12.63%，振幅较大的相关个股有Painreform Ltd.、Cyclo Therapeutics Inc C/Wts 11/12/2025、Sunshine Biopharma Inc C/Wts ，振幅分别为74.44%、35.46%、25.64%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021449a24adb7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021449a24adb7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4583","EBS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.emergentbiosolutions.com","stockEarnings":[{"period":"1week","weight":0.0529},{"period":"1month","weight":0.1034},{"period":"3month","weight":0.6765},{"period":"6month","weight":-0.2551},{"period":"1year","weight":-0.2558},{"period":"ytd","weight":-0.2301}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Emergent Biosolutions Inc.于1998年5月在美国密歇根州成立，随后在 2004年6月改为特拉华公司。公司拥有两个经营部门：生物防卫和生物科学。该公司是一家全球性生命科学公司，专注于提供创新的准备和响应解决方案，以应对意外、故意和自然发生的公共健康威胁。","yearOnYearQuotes":[{"month":1,"riseRate":0.736842,"avgChangeRate":0.048562},{"month":2,"riseRate":0.421053,"avgChangeRate":-0.000132},{"month":3,"riseRate":0.421053,"avgChangeRate":-0.035402},{"month":4,"riseRate":0.473684,"avgChangeRate":-0.035609},{"month":5,"riseRate":0.578947,"avgChangeRate":0.111206},{"month":6,"riseRate":0.631579,"avgChangeRate":0.011895},{"month":7,"riseRate":0.631579,"avgChangeRate":0.118526},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.041646},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.039909},{"month":10,"riseRate":0.555556,"avgChangeRate":0.008173},{"month":11,"riseRate":0.611111,"avgChangeRate":0.003568},{"month":12,"riseRate":0.578947,"avgChangeRate":0.040813}],"exchange":"NYSE","name":"Emergent Biosolutions","nameEN":"Emergent BioSolutions"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Emergent Biosolutions,EBS,Emergent Biosolutions股票,Emergent Biosolutions股票老虎,Emergent Biosolutions股票老虎国际,Emergent Biosolutions行情,Emergent Biosolutions股票行情,Emergent Biosolutions股价,Emergent Biosolutions股市,Emergent Biosolutions股票价格,Emergent Biosolutions股票交易,Emergent Biosolutions股票购买,Emergent Biosolutions股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}